Connect your AI

Cardinal Health CAH 2029

2029 at other companies

Avanos MedicalAVNS

——

SolventumSOLV

——

Medline, Inc. MDLN

——

Other financials

Income statement

Revenue$60.9B+11.0%

Gross profit$2.5B+17.7%

Operating income$509.0M-30.3%

Net income$399.0M-21.1%

EPS (diluted)$1.69-19.5%

Balance sheet

Cash & equivalents$3.9B+18.4%

Total debt$8.9B+16.1%

Total equity-$2.8B+3.9%

Total assets$56.7B+13.7%

Cash flow

Operating cash flow$1.8B-37.6%

CapEx$146.0M+15.9%

Free cash flow$1.7B-40.0%

Valuation

Market cap$55.64B+41.6%

Enterprise value$60.62B+34.8%

P/E35.8×+10.6×

P/S0.2×0.0×

Profitability

Gross margin3.8%+0.2pp

Operating margin0.9%-0.1pp

Net margin0.6%-0.1pp

FCF margin1.7%+0.6pp

Returns & leverage

Return on equity37.4%—

Debt / equity4.1×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's 2029.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cardinal Health's 2029?: Cardinal Health (CAH) reported 2029 of $740M in Q1 2026.
How has Cardinal Health's 2029 changed year-over-year?: Cardinal Health's 2029 decreased by 61.1% year-over-year, from $1.9B to $740M.